NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer. (2020)
Attributed to:
Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cancergen.2020.08.006
PubMed Identifier: 32871287
Publication URI: http://europepmc.org/abstract/MED/32871287
Type: Journal Article/Review
Volume: 248-249
Parent Publication: Cancer genetics